SMARCA2 and lung carcinoma: In our murine lung cancer model, we observed malignant adenocarcinomas in all four genotypes used in this experimental system, with a frequency of 99%, 80%, 73% and 48% for the DKO, Brg1-KO, Brm-null and wild type genotypes, respectively (as described in our tandem paper).